nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—colon cancer	0.541	1	CbGaD
Bepridil—Superinfection—Fluorouracil—colon cancer	0.0083	0.055	CcSEcCtD
Bepridil—Superinfection—Capecitabine—colon cancer	0.0058	0.0384	CcSEcCtD
Bepridil—Emotional distress—Fluorouracil—colon cancer	0.00443	0.0294	CcSEcCtD
Bepridil—Skin irritation—Fluorouracil—colon cancer	0.00436	0.0289	CcSEcCtD
Bepridil—Sudden death—Irinotecan—colon cancer	0.00385	0.0255	CcSEcCtD
Bepridil—PDE1A—smooth muscle tissue—colon cancer	0.00384	0.0308	CbGeAlD
Bepridil—PDE1A—renal system—colon cancer	0.00369	0.0296	CbGeAlD
Bepridil—Sudden death—Fluorouracil—colon cancer	0.00368	0.0244	CcSEcCtD
Bepridil—Akathisia—Irinotecan—colon cancer	0.00356	0.0236	CcSEcCtD
Bepridil—CALM2—endothelium—colon cancer	0.00347	0.0278	CbGeAlD
Bepridil—CALM1—endothelium—colon cancer	0.00345	0.0277	CbGeAlD
Bepridil—KCNQ1—renal system—colon cancer	0.00343	0.0275	CbGeAlD
Bepridil—ATP1A1—gall bladder—colon cancer	0.00342	0.0274	CbGeAlD
Bepridil—Sinus tachycardia—Capecitabine—colon cancer	0.00327	0.0217	CcSEcCtD
Bepridil—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00321	0.0212	CcSEcCtD
Bepridil—CALM2—blood vessel—colon cancer	0.0032	0.0257	CbGeAlD
Bepridil—CALM1—blood vessel—colon cancer	0.00319	0.0256	CbGeAlD
Bepridil—CALM2—gall bladder—colon cancer	0.00301	0.0242	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—colon cancer	0.00299	0.024	CbGeAlD
Bepridil—KCNQ1—digestive system—colon cancer	0.00282	0.0226	CbGeAlD
Bepridil—KCNQ1—bone marrow—colon cancer	0.0026	0.0208	CbGeAlD
Bepridil—CACNA2D2—vagina—colon cancer	0.00257	0.0207	CbGeAlD
Bepridil—Sudden death—Capecitabine—colon cancer	0.00257	0.0171	CcSEcCtD
Bepridil—CACNA1C—smooth muscle tissue—colon cancer	0.00228	0.0183	CbGeAlD
Bepridil—PDE1A—liver—colon cancer	0.00226	0.0181	CbGeAlD
Bepridil—Vasodilation procedure—Irinotecan—colon cancer	0.00224	0.0148	CcSEcCtD
Bepridil—Vasodilation—Irinotecan—colon cancer	0.00224	0.0148	CcSEcCtD
Bepridil—ATP1A1—embryo—colon cancer	0.00217	0.0174	CbGeAlD
Bepridil—Loss of libido—Methotrexate—colon cancer	0.00212	0.0141	CcSEcCtD
Bepridil—KCNQ1—liver—colon cancer	0.0021	0.0168	CbGeAlD
Bepridil—PDE1B—lymph node—colon cancer	0.00206	0.0166	CbGeAlD
Bepridil—TNNC1—lymph node—colon cancer	0.00198	0.0159	CbGeAlD
Bepridil—Sudden death—Methotrexate—colon cancer	0.00192	0.0127	CcSEcCtD
Bepridil—CALM3—smooth muscle tissue—colon cancer	0.00191	0.0153	CbGeAlD
Bepridil—CALM2—embryo—colon cancer	0.00191	0.0153	CbGeAlD
Bepridil—CALM1—embryo—colon cancer	0.0019	0.0152	CbGeAlD
Bepridil—Torsade de pointes—Capecitabine—colon cancer	0.00188	0.0124	CcSEcCtD
Bepridil—CACNA1C—digestive system—colon cancer	0.0018	0.0145	CbGeAlD
Bepridil—ATP1A1—epithelium—colon cancer	0.00177	0.0142	CbGeAlD
Bepridil—CACNA1H—liver—colon cancer	0.00176	0.0141	CbGeAlD
Bepridil—PDE1A—lymph node—colon cancer	0.00173	0.0139	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—colon cancer	0.0017	0.0137	CbGeAlD
Bepridil—CACNA2D2—lymph node—colon cancer	0.00167	0.0134	CbGeAlD
Bepridil—ATP1A1—renal system—colon cancer	0.00164	0.0132	CbGeAlD
Bepridil—KCNQ1—lymph node—colon cancer	0.00161	0.0129	CbGeAlD
Bepridil—CACNA1C—vagina—colon cancer	0.00159	0.0128	CbGeAlD
Bepridil—CALM2—epithelium—colon cancer	0.00156	0.0125	CbGeAlD
Bepridil—CALM1—epithelium—colon cancer	0.00155	0.0124	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—colon cancer	0.0015	0.012	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—colon cancer	0.00149	0.012	CbGeAlD
Bepridil—CACNA1D—liver—colon cancer	0.00145	0.0117	CbGeAlD
Bepridil—CALM2—renal system—colon cancer	0.00144	0.0116	CbGeAlD
Bepridil—CALM1—renal system—colon cancer	0.00144	0.0115	CbGeAlD
Bepridil—Cardiac failure—Fluorouracil—colon cancer	0.0014	0.00929	CcSEcCtD
Bepridil—CALM3—bone marrow—colon cancer	0.00139	0.0112	CbGeAlD
Bepridil—ATP1A1—lymphoid tissue—colon cancer	0.00136	0.0109	CbGeAlD
Bepridil—CACNA1H—lymph node—colon cancer	0.00135	0.0108	CbGeAlD
Bepridil—ATP1A1—digestive system—colon cancer	0.00135	0.0108	CbGeAlD
Bepridil—CALM3—vagina—colon cancer	0.00133	0.0107	CbGeAlD
Bepridil—KCNH2—renal system—colon cancer	0.00131	0.0105	CbGeAlD
Bepridil—ABCB1—blood vessel—colon cancer	0.00127	0.0102	CbGeAlD
Bepridil—ATP1A1—bone marrow—colon cancer	0.00124	0.00995	CbGeAlD
Bepridil—Angina pectoris—Irinotecan—colon cancer	0.0012	0.00797	CcSEcCtD
Bepridil—CALM2—lymphoid tissue—colon cancer	0.0012	0.00962	CbGeAlD
Bepridil—CALM1—lymphoid tissue—colon cancer	0.00119	0.00958	CbGeAlD
Bepridil—ATP1A1—vagina—colon cancer	0.00119	0.00953	CbGeAlD
Bepridil—CALM2—digestive system—colon cancer	0.00119	0.00951	CbGeAlD
Bepridil—CALM1—digestive system—colon cancer	0.00118	0.00946	CbGeAlD
Bepridil—Erectile dysfunction—Vincristine—colon cancer	0.00117	0.00774	CcSEcCtD
Bepridil—Angina pectoris—Fluorouracil—colon cancer	0.00115	0.00763	CcSEcCtD
Bepridil—Depression—Vincristine—colon cancer	0.00113	0.00747	CcSEcCtD
Bepridil—CALM3—liver—colon cancer	0.00112	0.00902	CbGeAlD
Bepridil—CACNA1D—lymph node—colon cancer	0.00111	0.00894	CbGeAlD
Bepridil—CALM2—bone marrow—colon cancer	0.00109	0.00876	CbGeAlD
Bepridil—CALM1—bone marrow—colon cancer	0.00109	0.00872	CbGeAlD
Bepridil—Sweating—Vincristine—colon cancer	0.00108	0.00718	CcSEcCtD
Bepridil—Sweating—Irinotecan—colon cancer	0.00106	0.00699	CcSEcCtD
Bepridil—CALM2—vagina—colon cancer	0.00105	0.0084	CbGeAlD
Bepridil—CALM1—vagina—colon cancer	0.00104	0.00836	CbGeAlD
Bepridil—CACNA1C—lymph node—colon cancer	0.00103	0.00826	CbGeAlD
Bepridil—Increased appetite—Capecitabine—colon cancer	0.00102	0.00674	CcSEcCtD
Bepridil—Bradycardia—Irinotecan—colon cancer	0.00101	0.00667	CcSEcCtD
Bepridil—ATP1A1—liver—colon cancer	0.001	0.00804	CbGeAlD
Bepridil—Rhinitis—Irinotecan—colon cancer	0.000991	0.00656	CcSEcCtD
Bepridil—KCNH2—bone marrow—colon cancer	0.00099	0.00794	CbGeAlD
Bepridil—Arthritis—Capecitabine—colon cancer	0.000984	0.00652	CcSEcCtD
Bepridil—Cardiac failure—Capecitabine—colon cancer	0.00098	0.00649	CcSEcCtD
Bepridil—Rhinitis—Fluorouracil—colon cancer	0.000949	0.00629	CcSEcCtD
Bepridil—KCNH2—vagina—colon cancer	0.000948	0.0076	CbGeAlD
Bepridil—Cardiac disorder—Vincristine—colon cancer	0.000942	0.00624	CcSEcCtD
Bepridil—Pharyngitis—Fluorouracil—colon cancer	0.00094	0.00622	CcSEcCtD
Bepridil—Cardiac disorder—Irinotecan—colon cancer	0.000917	0.00608	CcSEcCtD
Bepridil—Arrhythmia—Irinotecan—colon cancer	0.000883	0.00585	CcSEcCtD
Bepridil—CALM2—liver—colon cancer	0.000883	0.00708	CbGeAlD
Bepridil—Liver function test abnormal—Capecitabine—colon cancer	0.000883	0.00585	CcSEcCtD
Bepridil—CALM1—liver—colon cancer	0.000879	0.00705	CbGeAlD
Bepridil—CALM3—lymph node—colon cancer	0.000862	0.00691	CbGeAlD
Bepridil—Flatulence—Irinotecan—colon cancer	0.000848	0.00562	CcSEcCtD
Bepridil—Gastritis—Capecitabine—colon cancer	0.000846	0.00561	CcSEcCtD
Bepridil—Arrhythmia—Fluorouracil—colon cancer	0.000846	0.0056	CcSEcCtD
Bepridil—Influenza—Capecitabine—colon cancer	0.000826	0.00548	CcSEcCtD
Bepridil—Angina pectoris—Capecitabine—colon cancer	0.000805	0.00533	CcSEcCtD
Bepridil—CYP2D6—renal system—colon cancer	0.000798	0.0064	CbGeAlD
Bepridil—Vertigo—Vincristine—colon cancer	0.000794	0.00526	CcSEcCtD
Bepridil—Abdominal discomfort—Capecitabine—colon cancer	0.000792	0.00525	CcSEcCtD
Bepridil—Vision blurred—Fluorouracil—colon cancer	0.000777	0.00515	CcSEcCtD
Bepridil—Vertigo—Irinotecan—colon cancer	0.000773	0.00512	CcSEcCtD
Bepridil—Syncope—Irinotecan—colon cancer	0.000772	0.00511	CcSEcCtD
Bepridil—ATP1A1—lymph node—colon cancer	0.000769	0.00617	CbGeAlD
Bepridil—Hypertension—Vincristine—colon cancer	0.000763	0.00505	CcSEcCtD
Bepridil—ABCB1—embryo—colon cancer	0.000759	0.00609	CbGeAlD
Bepridil—Loss of consciousness—Irinotecan—colon cancer	0.000756	0.00501	CcSEcCtD
Bepridil—Myalgia—Vincristine—colon cancer	0.000752	0.00498	CcSEcCtD
Bepridil—Cough—Irinotecan—colon cancer	0.000751	0.00497	CcSEcCtD
Bepridil—Hypertension—Irinotecan—colon cancer	0.000743	0.00492	CcSEcCtD
Bepridil—Depression—Capecitabine—colon cancer	0.000735	0.00487	CcSEcCtD
Bepridil—Oedema—Vincristine—colon cancer	0.000721	0.00478	CcSEcCtD
Bepridil—Oedema—Irinotecan—colon cancer	0.000702	0.00465	CcSEcCtD
Bepridil—Myalgia—Fluorouracil—colon cancer	0.000702	0.00465	CcSEcCtD
Bepridil—Hyperhidrosis—Vincristine—colon cancer	0.000697	0.00462	CcSEcCtD
Bepridil—Shock—Irinotecan—colon cancer	0.000691	0.00458	CcSEcCtD
Bepridil—Anorexia—Vincristine—colon cancer	0.000687	0.00455	CcSEcCtD
Bepridil—Hyperhidrosis—Irinotecan—colon cancer	0.000679	0.0045	CcSEcCtD
Bepridil—CALM2—lymph node—colon cancer	0.000677	0.00543	CbGeAlD
Bepridil—CALM1—lymph node—colon cancer	0.000674	0.00541	CbGeAlD
Bepridil—Bradycardia—Capecitabine—colon cancer	0.000673	0.00446	CcSEcCtD
Bepridil—Oedema—Fluorouracil—colon cancer	0.000673	0.00446	CcSEcCtD
Bepridil—Anorexia—Irinotecan—colon cancer	0.000669	0.00443	CcSEcCtD
Bepridil—Rhinitis—Capecitabine—colon cancer	0.000663	0.00439	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—colon cancer	0.000657	0.00435	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Vincristine—colon cancer	0.000657	0.00435	CcSEcCtD
Bepridil—Pharyngitis—Capecitabine—colon cancer	0.000657	0.00435	CcSEcCtD
Bepridil—CYP2D6—digestive system—colon cancer	0.000655	0.00525	CbGeAlD
Bepridil—Insomnia—Vincristine—colon cancer	0.000652	0.00432	CcSEcCtD
Bepridil—Paraesthesia—Vincristine—colon cancer	0.000647	0.00429	CcSEcCtD
Bepridil—Anorexia—Fluorouracil—colon cancer	0.000641	0.00425	CcSEcCtD
Bepridil—Insomnia—Irinotecan—colon cancer	0.000635	0.00421	CcSEcCtD
Bepridil—Paraesthesia—Irinotecan—colon cancer	0.000631	0.00418	CcSEcCtD
Bepridil—Decreased appetite—Vincristine—colon cancer	0.000627	0.00415	CcSEcCtD
Bepridil—Dyspnoea—Irinotecan—colon cancer	0.000626	0.00415	CcSEcCtD
Bepridil—Somnolence—Irinotecan—colon cancer	0.000624	0.00414	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vincristine—colon cancer	0.000623	0.00412	CcSEcCtD
Bepridil—ABCB1—epithelium—colon cancer	0.000619	0.00497	CbGeAlD
Bepridil—Dyspepsia—Irinotecan—colon cancer	0.000618	0.0041	CcSEcCtD
Bepridil—Tinnitus—Capecitabine—colon cancer	0.000617	0.00409	CcSEcCtD
Bepridil—Pain—Vincristine—colon cancer	0.000617	0.00409	CcSEcCtD
Bepridil—Constipation—Vincristine—colon cancer	0.000617	0.00409	CcSEcCtD
Bepridil—Cardiac disorder—Capecitabine—colon cancer	0.000614	0.00407	CcSEcCtD
Bepridil—KCNH2—lymph node—colon cancer	0.000613	0.00492	CbGeAlD
Bepridil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000613	0.00406	CcSEcCtD
Bepridil—Decreased appetite—Irinotecan—colon cancer	0.00061	0.00404	CcSEcCtD
Bepridil—Insomnia—Fluorouracil—colon cancer	0.000608	0.00403	CcSEcCtD
Bepridil—Gastrointestinal disorder—Irinotecan—colon cancer	0.000606	0.00402	CcSEcCtD
Bepridil—Paraesthesia—Fluorouracil—colon cancer	0.000604	0.004	CcSEcCtD
Bepridil—Constipation—Irinotecan—colon cancer	0.000601	0.00398	CcSEcCtD
Bepridil—Pain—Irinotecan—colon cancer	0.000601	0.00398	CcSEcCtD
Bepridil—Dyspnoea—Fluorouracil—colon cancer	0.0006	0.00397	CcSEcCtD
Bepridil—Somnolence—Fluorouracil—colon cancer	0.000598	0.00396	CcSEcCtD
Bepridil—Dyspepsia—Fluorouracil—colon cancer	0.000592	0.00392	CcSEcCtD
Bepridil—Arrhythmia—Capecitabine—colon cancer	0.000591	0.00392	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—colon cancer	0.00059	0.00391	CcSEcCtD
Bepridil—Gastrointestinal pain—Vincristine—colon cancer	0.00059	0.00391	CcSEcCtD
Bepridil—Decreased appetite—Fluorouracil—colon cancer	0.000585	0.00387	CcSEcCtD
Bepridil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000581	0.00385	CcSEcCtD
Bepridil—Pain—Fluorouracil—colon cancer	0.000575	0.00381	CcSEcCtD
Bepridil—Gastrointestinal pain—Irinotecan—colon cancer	0.000574	0.0038	CcSEcCtD
Bepridil—ABCB1—renal system—colon cancer	0.000574	0.00461	CbGeAlD
Bepridil—Body temperature increased—Vincristine—colon cancer	0.00057	0.00378	CcSEcCtD
Bepridil—Abdominal pain—Vincristine—colon cancer	0.00057	0.00378	CcSEcCtD
Bepridil—Flatulence—Capecitabine—colon cancer	0.000567	0.00376	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—colon cancer	0.000567	0.00375	CcSEcCtD
Bepridil—Body temperature increased—Irinotecan—colon cancer	0.000555	0.00368	CcSEcCtD
Bepridil—Abdominal pain—Irinotecan—colon cancer	0.000555	0.00368	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—colon cancer	0.000549	0.00363	CcSEcCtD
Bepridil—Depression—Methotrexate—colon cancer	0.000547	0.00362	CcSEcCtD
Bepridil—Vision blurred—Capecitabine—colon cancer	0.000543	0.0036	CcSEcCtD
Bepridil—Tremor—Capecitabine—colon cancer	0.00054	0.00357	CcSEcCtD
Bepridil—Body temperature increased—Fluorouracil—colon cancer	0.000532	0.00352	CcSEcCtD
Bepridil—Sweating—Methotrexate—colon cancer	0.000526	0.00348	CcSEcCtD
Bepridil—Vertigo—Capecitabine—colon cancer	0.000517	0.00343	CcSEcCtD
Bepridil—Asthenia—Vincristine—colon cancer	0.000517	0.00343	CcSEcCtD
Bepridil—Syncope—Capecitabine—colon cancer	0.000516	0.00342	CcSEcCtD
Bepridil—Palpitations—Capecitabine—colon cancer	0.000509	0.00337	CcSEcCtD
Bepridil—Loss of consciousness—Capecitabine—colon cancer	0.000506	0.00335	CcSEcCtD
Bepridil—Asthenia—Irinotecan—colon cancer	0.000504	0.00334	CcSEcCtD
Bepridil—Cough—Capecitabine—colon cancer	0.000503	0.00333	CcSEcCtD
Bepridil—Hypertension—Capecitabine—colon cancer	0.000497	0.00329	CcSEcCtD
Bepridil—Diarrhoea—Vincristine—colon cancer	0.000493	0.00327	CcSEcCtD
Bepridil—Myalgia—Capecitabine—colon cancer	0.00049	0.00325	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—colon cancer	0.000489	0.00324	CcSEcCtD
Bepridil—Anxiety—Capecitabine—colon cancer	0.000489	0.00324	CcSEcCtD
Bepridil—CYP2D6—liver—colon cancer	0.000488	0.00391	CbGeAlD
Bepridil—Diarrhoea—Irinotecan—colon cancer	0.00048	0.00318	CcSEcCtD
Bepridil—Dry mouth—Capecitabine—colon cancer	0.000479	0.00318	CcSEcCtD
Bepridil—Dizziness—Vincristine—colon cancer	0.000477	0.00316	CcSEcCtD
Bepridil—ABCB1—lymphoid tissue—colon cancer	0.000477	0.00382	CbGeAlD
Bepridil—ABCB1—digestive system—colon cancer	0.000471	0.00378	CbGeAlD
Bepridil—Oedema—Capecitabine—colon cancer	0.00047	0.00311	CcSEcCtD
Bepridil—Dizziness—Irinotecan—colon cancer	0.000464	0.00308	CcSEcCtD
Bepridil—Shock—Capecitabine—colon cancer	0.000462	0.00306	CcSEcCtD
Bepridil—Diarrhoea—Fluorouracil—colon cancer	0.00046	0.00305	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—colon cancer	0.000459	0.00304	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—colon cancer	0.000457	0.00303	CcSEcCtD
Bepridil—Rash—Vincristine—colon cancer	0.000455	0.00301	CcSEcCtD
Bepridil—Hyperhidrosis—Capecitabine—colon cancer	0.000454	0.00301	CcSEcCtD
Bepridil—Dermatitis—Vincristine—colon cancer	0.000454	0.00301	CcSEcCtD
Bepridil—Headache—Vincristine—colon cancer	0.000452	0.00299	CcSEcCtD
Bepridil—Anorexia—Capecitabine—colon cancer	0.000448	0.00297	CcSEcCtD
Bepridil—Dizziness—Fluorouracil—colon cancer	0.000445	0.00295	CcSEcCtD
Bepridil—Rash—Irinotecan—colon cancer	0.000443	0.00293	CcSEcCtD
Bepridil—Dermatitis—Irinotecan—colon cancer	0.000442	0.00293	CcSEcCtD
Bepridil—Headache—Irinotecan—colon cancer	0.00044	0.00291	CcSEcCtD
Bepridil—ABCB1—bone marrow—colon cancer	0.000434	0.00348	CbGeAlD
Bepridil—Nausea—Vincristine—colon cancer	0.000428	0.00284	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000428	0.00284	CcSEcCtD
Bepridil—Insomnia—Capecitabine—colon cancer	0.000425	0.00282	CcSEcCtD
Bepridil—Rash—Fluorouracil—colon cancer	0.000424	0.00281	CcSEcCtD
Bepridil—Dermatitis—Fluorouracil—colon cancer	0.000424	0.00281	CcSEcCtD
Bepridil—Paraesthesia—Capecitabine—colon cancer	0.000422	0.0028	CcSEcCtD
Bepridil—Headache—Fluorouracil—colon cancer	0.000421	0.00279	CcSEcCtD
Bepridil—Dyspnoea—Capecitabine—colon cancer	0.000419	0.00278	CcSEcCtD
Bepridil—Nausea—Irinotecan—colon cancer	0.000417	0.00276	CcSEcCtD
Bepridil—ABCB1—vagina—colon cancer	0.000416	0.00334	CbGeAlD
Bepridil—Dyspepsia—Capecitabine—colon cancer	0.000414	0.00274	CcSEcCtD
Bepridil—Decreased appetite—Capecitabine—colon cancer	0.000409	0.00271	CcSEcCtD
Bepridil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000406	0.00269	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—colon cancer	0.000404	0.00268	CcSEcCtD
Bepridil—Pain—Capecitabine—colon cancer	0.000402	0.00266	CcSEcCtD
Bepridil—Constipation—Capecitabine—colon cancer	0.000402	0.00266	CcSEcCtD
Bepridil—Nausea—Fluorouracil—colon cancer	0.0004	0.00265	CcSEcCtD
Bepridil—Vertigo—Methotrexate—colon cancer	0.000385	0.00255	CcSEcCtD
Bepridil—Gastrointestinal pain—Capecitabine—colon cancer	0.000384	0.00255	CcSEcCtD
Bepridil—Cough—Methotrexate—colon cancer	0.000374	0.00248	CcSEcCtD
Bepridil—Abdominal pain—Capecitabine—colon cancer	0.000372	0.00246	CcSEcCtD
Bepridil—Body temperature increased—Capecitabine—colon cancer	0.000372	0.00246	CcSEcCtD
Bepridil—Myalgia—Methotrexate—colon cancer	0.000365	0.00242	CcSEcCtD
Bepridil—ABCB1—liver—colon cancer	0.000351	0.00281	CbGeAlD
Bepridil—Hyperhidrosis—Methotrexate—colon cancer	0.000338	0.00224	CcSEcCtD
Bepridil—Asthenia—Capecitabine—colon cancer	0.000337	0.00223	CcSEcCtD
Bepridil—Anorexia—Methotrexate—colon cancer	0.000334	0.00221	CcSEcCtD
Bepridil—Diarrhoea—Capecitabine—colon cancer	0.000322	0.00213	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000319	0.00211	CcSEcCtD
Bepridil—Insomnia—Methotrexate—colon cancer	0.000316	0.0021	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—colon cancer	0.000314	0.00208	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—colon cancer	0.000312	0.00207	CcSEcCtD
Bepridil—Somnolence—Methotrexate—colon cancer	0.000311	0.00206	CcSEcCtD
Bepridil—Dizziness—Capecitabine—colon cancer	0.000311	0.00206	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—colon cancer	0.000308	0.00204	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—colon cancer	0.000304	0.00201	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000302	0.002	CcSEcCtD
Bepridil—Pain—Methotrexate—colon cancer	0.000299	0.00198	CcSEcCtD
Bepridil—Rash—Capecitabine—colon cancer	0.000296	0.00196	CcSEcCtD
Bepridil—Dermatitis—Capecitabine—colon cancer	0.000296	0.00196	CcSEcCtD
Bepridil—Headache—Capecitabine—colon cancer	0.000294	0.00195	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—colon cancer	0.000286	0.0019	CcSEcCtD
Bepridil—Nausea—Capecitabine—colon cancer	0.000279	0.00185	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—colon cancer	0.000277	0.00183	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—colon cancer	0.000277	0.00183	CcSEcCtD
Bepridil—ABCB1—lymph node—colon cancer	0.000269	0.00216	CbGeAlD
Bepridil—Asthenia—Methotrexate—colon cancer	0.000251	0.00166	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—colon cancer	0.000239	0.00159	CcSEcCtD
Bepridil—Dizziness—Methotrexate—colon cancer	0.000231	0.00153	CcSEcCtD
Bepridil—Rash—Methotrexate—colon cancer	0.000221	0.00146	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—colon cancer	0.00022	0.00146	CcSEcCtD
Bepridil—Headache—Methotrexate—colon cancer	0.000219	0.00145	CcSEcCtD
Bepridil—Nausea—Methotrexate—colon cancer	0.000208	0.00138	CcSEcCtD
Bepridil—PDE1A—Disease—AKT1—colon cancer	2.22e-05	0.000121	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—KRAS—colon cancer	2.21e-05	0.000121	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NRAS—colon cancer	2.2e-05	0.00012	CbGpPWpGaD
Bepridil—PDE1B—Immune System—AKT1—colon cancer	2.2e-05	0.00012	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—colon cancer	2.19e-05	0.00012	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NRAS—colon cancer	2.15e-05	0.000117	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NRAS—colon cancer	2.15e-05	0.000117	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—KRAS—colon cancer	2.14e-05	0.000117	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—KRAS—colon cancer	2.14e-05	0.000117	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PIK3CA—colon cancer	2.13e-05	0.000116	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—colon cancer	2.11e-05	0.000115	CbGpPWpGaD
Bepridil—CALM3—Disease—APC—colon cancer	2.11e-05	0.000115	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDH1—colon cancer	2.1e-05	0.000115	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KRAS—colon cancer	2.07e-05	0.000113	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MYC—colon cancer	2.05e-05	0.000112	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—colon cancer	2.04e-05	0.000112	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—colon cancer	2.04e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—colon cancer	2.04e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Disease—APC—colon cancer	2.04e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Disease—APC—colon cancer	2.04e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—PIK3CA—colon cancer	2.03e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDH1—colon cancer	2.03e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDH1—colon cancer	2.03e-05	0.000111	CbGpPWpGaD
Bepridil—PDE1B—Disease—AKT1—colon cancer	2.03e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—colon cancer	2.03e-05	0.000111	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—colon cancer	2e-05	0.000109	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KRAS—colon cancer	1.99e-05	0.000109	CbGpPWpGaD
Bepridil—CALM3—Disease—BRAF—colon cancer	1.98e-05	0.000108	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—colon cancer	1.97e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—PIK3CA—colon cancer	1.97e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—PIK3CA—colon cancer	1.97e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—colon cancer	1.96e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—colon cancer	1.96e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KRAS—colon cancer	1.93e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KRAS—colon cancer	1.93e-05	0.000105	CbGpPWpGaD
Bepridil—CALM2—Disease—BRAF—colon cancer	1.92e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Disease—BRAF—colon cancer	1.92e-05	0.000105	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KRAS—colon cancer	1.91e-05	0.000104	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—colon cancer	1.9e-05	0.000104	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—colon cancer	1.9e-05	0.000104	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—PIK3CA—colon cancer	1.9e-05	0.000104	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KRAS—colon cancer	1.89e-05	0.000103	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—HRAS—colon cancer	1.88e-05	0.000103	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PIK3CA—colon cancer	1.87e-05	0.000102	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KRAS—colon cancer	1.85e-05	0.000101	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KRAS—colon cancer	1.85e-05	0.000101	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—colon cancer	1.84e-05	0.0001	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—PIK3CA—colon cancer	1.83e-05	0.0001	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TYMS—colon cancer	1.82e-05	9.95e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—HRAS—colon cancer	1.82e-05	9.94e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—HRAS—colon cancer	1.82e-05	9.94e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—PIK3CA—colon cancer	1.77e-05	9.67e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—PIK3CA—colon cancer	1.77e-05	9.67e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—colon cancer	1.76e-05	9.6e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—PIK3CA—colon cancer	1.76e-05	9.6e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ABCB1—colon cancer	1.75e-05	9.55e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—colon cancer	1.74e-05	9.5e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PIK3CA—colon cancer	1.74e-05	9.5e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TYMS—colon cancer	1.72e-05	9.38e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—colon cancer	1.7e-05	9.3e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—PIK3CA—colon cancer	1.7e-05	9.29e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—PIK3CA—colon cancer	1.7e-05	9.29e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—colon cancer	1.69e-05	9.25e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—colon cancer	1.68e-05	9.19e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—colon cancer	1.66e-05	9.07e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—colon cancer	1.65e-05	9e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—colon cancer	1.65e-05	9e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—colon cancer	1.64e-05	8.95e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—colon cancer	1.64e-05	8.95e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—colon cancer	1.63e-05	8.88e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—colon cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGFR3—colon cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—colon cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—colon cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—colon cancer	1.6e-05	8.74e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—colon cancer	1.57e-05	8.59e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—colon cancer	1.57e-05	8.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGFR3—colon cancer	1.55e-05	8.49e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGFR3—colon cancer	1.55e-05	8.49e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—colon cancer	1.55e-05	8.48e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTNNB1—colon cancer	1.55e-05	8.47e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—colon cancer	1.55e-05	8.45e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—colon cancer	1.55e-05	8.45e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—colon cancer	1.53e-05	8.34e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDKN1A—colon cancer	1.51e-05	8.27e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTNNB1—colon cancer	1.5e-05	8.19e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTNNB1—colon cancer	1.5e-05	8.19e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—colon cancer	1.5e-05	8.17e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APC—colon cancer	1.48e-05	8.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—NRAS—colon cancer	1.48e-05	8.06e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1A—colon cancer	1.47e-05	8e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1A—colon cancer	1.47e-05	8e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—colon cancer	1.45e-05	7.9e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—colon cancer	1.45e-05	7.9e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EP300—colon cancer	1.44e-05	7.87e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—colon cancer	1.44e-05	7.84e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—colon cancer	1.43e-05	7.82e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—colon cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—colon cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—colon cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—colon cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—colon cancer	1.42e-05	7.76e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—SRC—colon cancer	1.4e-05	7.65e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1A—colon cancer	1.4e-05	7.64e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EP300—colon cancer	1.39e-05	7.61e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EP300—colon cancer	1.39e-05	7.61e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—colon cancer	1.39e-05	7.59e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—colon cancer	1.39e-05	7.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BRAF—colon cancer	1.39e-05	7.58e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—colon cancer	1.38e-05	7.56e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—colon cancer	1.38e-05	7.56e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—SRC—colon cancer	1.36e-05	7.4e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—SRC—colon cancer	1.36e-05	7.4e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1A—colon cancer	1.35e-05	7.39e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1A—colon cancer	1.35e-05	7.39e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—colon cancer	1.35e-05	7.36e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—colon cancer	1.34e-05	7.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BRAF—colon cancer	1.34e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BRAF—colon cancer	1.34e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—colon cancer	1.34e-05	7.32e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EP300—colon cancer	1.33e-05	7.27e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—colon cancer	1.3e-05	7.12e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—colon cancer	1.3e-05	7.12e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—colon cancer	1.3e-05	7.1e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—colon cancer	1.3e-05	7.1e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—colon cancer	1.3e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—colon cancer	1.3e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SRC—colon cancer	1.29e-05	7.07e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—colon cancer	1.29e-05	7.05e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EP300—colon cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EP300—colon cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—colon cancer	1.27e-05	6.94e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SRC—colon cancer	1.25e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SRC—colon cancer	1.25e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—colon cancer	1.24e-05	6.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—colon cancer	1.23e-05	6.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—colon cancer	1.23e-05	6.71e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—colon cancer	1.23e-05	6.71e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—colon cancer	1.22e-05	6.64e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—colon cancer	1.2e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—colon cancer	1.2e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—colon cancer	1.19e-05	6.49e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—colon cancer	1.19e-05	6.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—colon cancer	1.17e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—colon cancer	1.16e-05	6.34e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—colon cancer	1.16e-05	6.33e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—colon cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—colon cancer	1.13e-05	6.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—colon cancer	1.13e-05	6.16e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—colon cancer	1.13e-05	6.16e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—colon cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—colon cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—colon cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—colon cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—colon cancer	1.12e-05	6.11e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—colon cancer	1.12e-05	6.11e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—EP300—colon cancer	1.11e-05	6.09e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—colon cancer	1.1e-05	5.99e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—colon cancer	1.1e-05	5.99e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—colon cancer	1.08e-05	5.9e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—EP300—colon cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—EP300—colon cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—colon cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—colon cancer	1.07e-05	5.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—colon cancer	1.04e-05	5.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—colon cancer	1.04e-05	5.7e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—colon cancer	1.04e-05	5.68e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—colon cancer	1.04e-05	5.66e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—colon cancer	1.04e-05	5.66e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—colon cancer	1.03e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—colon cancer	1.03e-05	5.63e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—colon cancer	1.02e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—colon cancer	1.01e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—colon cancer	1.01e-05	5.49e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—colon cancer	1.01e-05	5.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—colon cancer	1e-05	5.48e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—colon cancer	9.86e-06	5.39e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—colon cancer	9.84e-06	5.38e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1A—colon cancer	9.79e-06	5.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—colon cancer	9.79e-06	5.35e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—colon cancer	9.79e-06	5.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—colon cancer	9.7e-06	5.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—colon cancer	9.7e-06	5.3e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—colon cancer	9.57e-06	5.23e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—colon cancer	9.54e-06	5.21e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—colon cancer	9.54e-06	5.21e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—colon cancer	9.53e-06	5.21e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—colon cancer	9.52e-06	5.2e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—colon cancer	9.52e-06	5.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1A—colon cancer	9.47e-06	5.17e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1A—colon cancer	9.47e-06	5.17e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EP300—colon cancer	9.32e-06	5.09e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—colon cancer	9.22e-06	5.04e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—colon cancer	9.22e-06	5.04e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—colon cancer	9.11e-06	4.97e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SRC—colon cancer	9.06e-06	4.95e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EP300—colon cancer	9.01e-06	4.92e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EP300—colon cancer	9.01e-06	4.92e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—colon cancer	8.83e-06	4.82e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—colon cancer	8.81e-06	4.81e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—colon cancer	8.81e-06	4.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SRC—colon cancer	8.77e-06	4.79e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SRC—colon cancer	8.77e-06	4.79e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—colon cancer	8.72e-06	4.76e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—colon cancer	8.71e-06	4.76e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—colon cancer	8.54e-06	4.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—colon cancer	8.54e-06	4.66e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—EP300—colon cancer	8.45e-06	4.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—colon cancer	8.43e-06	4.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—colon cancer	8.43e-06	4.61e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—colon cancer	8.42e-06	4.6e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—colon cancer	8.42e-06	4.6e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—colon cancer	8.24e-06	4.5e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—colon cancer	8.12e-06	4.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—colon cancer	8.1e-06	4.42e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—colon cancer	8.04e-06	4.39e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—colon cancer	7.97e-06	4.36e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—colon cancer	7.97e-06	4.36e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—EP300—colon cancer	7.96e-06	4.35e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—colon cancer	7.94e-06	4.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—colon cancer	7.85e-06	4.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—colon cancer	7.85e-06	4.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—colon cancer	7.84e-06	4.28e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—colon cancer	7.84e-06	4.28e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—colon cancer	7.78e-06	4.25e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—colon cancer	7.78e-06	4.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—colon cancer	7.68e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—colon cancer	7.68e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—colon cancer	7.5e-06	4.1e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—colon cancer	7.26e-06	3.96e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—colon cancer	7.26e-06	3.96e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—colon cancer	6.89e-06	3.76e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—colon cancer	6.73e-06	3.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—colon cancer	6.67e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—colon cancer	6.67e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—colon cancer	6.67e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—colon cancer	6.51e-06	3.56e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—colon cancer	6.51e-06	3.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—colon cancer	6.45e-06	3.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—colon cancer	6.45e-06	3.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—colon cancer	6.38e-06	3.48e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—colon cancer	6.25e-06	3.41e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—colon cancer	6.17e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—colon cancer	6.17e-06	3.37e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—colon cancer	5.89e-06	3.22e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—colon cancer	5.63e-06	3.08e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—colon cancer	5.45e-06	2.97e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—colon cancer	5.45e-06	2.97e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—colon cancer	5.1e-06	2.79e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—colon cancer	4.81e-06	2.63e-05	CbGpPWpGaD
